Rosenblatt Positive on NVIDIA-Marvell Partnership

1 min read Reproduced verbatim
Rating
Positive
Target
N/A
No target in this note
Upside
N/A
No target to measure

Rosenblatt’s latest target on NVIDIA is now $300 (Nov 12, 2026); the median of 30 firms is $290. Rosenblatt has reached 60% of its year-old targets (20 scored).

Rosenblatt and NVIDIA logos

What the analyst said

Rosenblatt Positive on NVDA and MRVL Partnership.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Track record

Firm track recordRosenblatt: 60% of its 20 targets at least a year old were reached within 12 months (#24 of 26 firms); on NVIDIA, 3 of 5. Accuracy ranking →

Rosenblatt on NVIDIA

Rosenblatt price targets on NVIDIA

8 calls from December 26, 2025 to August 27, 2026. The target went from $245 to $390 (+59%). The rating stayed Buy.

Rosenblatt targetNVDA share price
  1. August 27, 2026Target raised from $325 (+20%)Buy$390
  2. August 24, 2026Kept the $325 targetBuy$325
  3. March 31, 2026 This noteRating only, no price targetBuyNo target
  4. March 23, 2026Kept the $325 targetBuy$325
  5. March 18, 2026Kept the $325 targetBuy$325
  6. March 17, 2026Target raised from $300 (+8%)Buy$325
  7. February 26, 2026Target raised from $245 (+22%)Buy$300
  8. December 26, 2025Earliest call shownBuy$245
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.